ESM Table 3 List of FDA reports.xls
收藏官方服务：
资源简介：
Detailed characteristics of diabetic ketoacidosis (DKA) reports where a sodium glucose cotransporter inhibitor (SGLT2i) was listed among suspect or concomitant drug in the FDA Adverse Event Reporting System from 2014 Q1 to 2016 Q3.Fadini GP, Bonora BM, Avogaro A. SGLT2 inhibitors and diabetic ketoacidosis. Data from the FDA Adverse Event Reporting System. Diabetologia 2017<br><br><br>
提供机构：
figshare创建时间：
2017-04-24
